JournalsHub
.online
Find My Journal
SR

S. Michael Rothenberg

Independent Researcher

ORCID iD 0000-0001-7333-3322
276
Publications
8,206
Citations
33
H-Index
46
i10-Index
0.44
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

276 total

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer PDF

Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Herbert H. Loong, Melissa L. Johnson et al. - New England Journal of Medicine, 2020
Cited by 822 OpenAlex

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers PDF

Lori J. Wirth, Eric J. Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang et al. - New England Journal of Medicine, 2020
Cited by 751 OpenAlex

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies PDF

Benjamin Solomon, Lavinia Tan, W. Marston Linehan, Stephen Q. Wong, Sebastian Hollizeck et al. - Journal of Thoracic Oncology, 2020
Cited by 278 OpenAlex

Selective RET kinase inhibition for patients with RET-altered cancers PDF

Vivek Subbiah, Vamsidhar Velcheti, Brian B. Tuch, Kevin Ebata, Naifa L. Busaidy et al. - Annals of Oncology, 2018
Cited by 428 OpenAlex

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors PDF

Alexander Drilon, Ramamoorthy Nagasubramanian, James F. Blake, Nora Ku, Brian B. Tuch et al. - Cancer Discovery, 2017
Cited by 429 OpenAlex

Redifferentiation of Iodine-Refractory <i>BRAF</i> V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib

S. Michael Rothenberg, David G. McFadden, Edwin L. Palmer, Gilbert H. Daniels, Lori J. Wirth - Clinical Cancer Research, 2014
Cited by 364 OpenAlex

The molecular pathogenesis of head and neck squamous cell carcinoma PDF

S. Michael Rothenberg, Leif W. Ellisen - Journal of Clinical Investigation, 2012
Cited by 360 OpenAlex

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy PDF

Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao, Christine Thumann, Isabel Fofana et al. - Nature Medicine, 2011
Cited by 690 OpenAlex

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip PDF

Shannon L. Stott, Chia‐Hsien Hsu, Dina Tsukrov, Min Yu, David T. Miyamoto et al. - Proceedings of the National Academy of Sciences, 2010
Cited by 1,618 OpenAlex

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling PDF

Ultan McDermott, Sreenath V. Sharma, Lori Dowell, Patricia Greninger, Clara Montagut et al. - Proceedings of the National Academy of Sciences, 2007
Cited by 358 OpenAlex

Research Topics

Protein Tyrosine Phosphatases (81) RNA modifications and cancer (70) Colorectal Cancer Treatments and Studies (51) Biochemical and Molecular Research (48) Melanoma and MAPK Pathways (47)

Affiliations

Memorial Sloan Kettering Cancer Center
US 2020 - 2020
Howard Hughes Medical Institute
US 2011 - 2008
Harvard University
US 2015 - 2007
University of California, Los Angeles
US 2013 - 2013
Eli Lilly (United States)
US 2021 - 2019

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now